173 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
Statements" and "Use of Non-GAAP Financial Information."
Environmental, Social & Governance (ESG)
As a leading biopharmaceutical company, Bristol
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
STRATEGY & GOVERNANCE Conducted a revised global ESG materiality assessment Expanded ESG operating model to further align with company strategy … Established ESG Council in 2022 as primary governance body for all ESG matters As a leading biopharma company, we understand our responsibility extends well
8-K
EX-99.1
g81gf5
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K/A
jbd 6a0g2z4v
31 Oct 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
247p05bt ul1be6t0
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
2t0cj29n
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
8ajhl7k
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
edsbivxwktnd6a6j
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
ej0ncyszq55399t gy
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
12m102yfovt
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
8-K
EX-99.1
y2vv020 r3
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
DEFA14A
bbodk9
20 Apr 22
Additional proxy soliciting materials
4:30pm
PX14A6G
iytykcszjgmkzkbanu
5 Apr 22
Letter to shareholders
4:53pm
8-K
EX-99.1
al0p4dkz
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am